These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4220002)

  • 1. The C3 nephritic factor (C3NeF) and the heat labile complement inactivator (HLCI) in chronic hypocomplementemic mesangioproliferative glomerulonephritis.
    Berthoux FC; Carpenter CB; Traeger J; Merrill JP
    Adv Nephrol Necker Hosp; 1974; 4():91-108. PubMed ID: 4220002
    [No Abstract]   [Full Text] [Related]  

  • 2. Human glomerulonephritis and the C3 nephritic factor (C3NeF).
    Berthoux FC; Carpenter CB; Freyria AM; Traeger J; Merrill JP
    Clin Nephrol; 1976 Mar; 5(3):93-100. PubMed ID: 57022
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complement activating factors in hypocomplementemic membranoproliferative glomerulonephritis (MPGN) patients' sera--comparison with C3NeF positive and negative cases].
    Ohmori F; Ohi H; Seki M; Watanabe S; Hatano M
    Nihon Jinzo Gakkai Shi; 1987 Apr; 29(4):493-8. PubMed ID: 3656707
    [No Abstract]   [Full Text] [Related]  

  • 5. C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Jan; 116(1):1-7. PubMed ID: 1245733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3neF).
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Feb; 116(2):568-70. PubMed ID: 1249423
    [No Abstract]   [Full Text] [Related]  

  • 7. C3 nephritic factor and hypocomplementaemia in a clinically healthy individual.
    Gewurz AT; Imherr SM; Strauss S; Gewurz H; Mold C
    Clin Exp Immunol; 1983 Oct; 54(1):253-8. PubMed ID: 6616970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephritic factor, C3 splitting activity, C3 and factor B breakdown products in glomerular diseases.
    De Vecchi A; Montagnino G; Scalia P; Tarantino A
    Ric Clin Lab; 1980; 10(1):93-7. PubMed ID: 6781054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Complement].
    Kourilsky O
    Ric Clin Lab; 1977; 7 Suppl 2():31-55. PubMed ID: 594564
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement and mesangiocapillary glomerulonephritis: the role of complement deficiency in glomerulonephritis.
    Peters DK; Williams DG
    Adv Nephrol Necker Hosp; 1974; 4():67-78. PubMed ID: 4220000
    [No Abstract]   [Full Text] [Related]  

  • 11. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Int J Pediatr Nephrol; 1985; 6(1):17-24. PubMed ID: 3997368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Glomerulonephritis, complement and C3NeF.
    Fearon DT
    N Engl J Med; 1976 Feb; 294(9):495-7. PubMed ID: 1246336
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of hypocomplementemic mesangiocapillary glomerulonephritis: appearance of C3 NeF and another factor.
    Seki M; Ohi H; Watanabe S; Kojima H; Fujita T; Hatano M
    Nihon Jinzo Gakkai Shi; 1987 May; 29(5):585-8. PubMed ID: 3656714
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
    Davis AE; Arnaout MA; Alper CA; Rosen FS
    N Engl J Med; 1977 Jul; 297(3):144-5. PubMed ID: 865586
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel C3 nephritic factor activity in the glomerulonephritis of staphylococcal endocarditis.
    Craddock CF; Richards NP; Powell RJ; Morgan AG
    Q J Med; 1987 Nov; 65(247):895-8. PubMed ID: 3455546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement system in pediatric renal disease.
    Arroyave CM
    Paediatrician; 1979; 8(5-6):349-63. PubMed ID: 392407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiology and clinical importance of the complement system of man.
    Spitzer RE
    Adv Pediatr; 1977; 24():43-101. PubMed ID: 341668
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesangiocapillary glomerulonephritis and persistent hypocomplementemia.
    Cameron JS; Ogg CS; Turner DR; Weller RO; White RH; Glasgow EF; Peters DK; Martin A
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():541-56. PubMed ID: 4220250
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal transplantation in mesangioproliferative glomerulonephritis (MPGN): relationship between the high frquency of recurrent glomerulonephritis and hypocomplementemia.
    Berthoux FC; Ducret F; Colon S; Blanc-Brunat N; Zech PY; Traeger J
    Kidney Int Suppl; 1975 Feb; (3):323-7. PubMed ID: 1099312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.